ID: ALA2273092

Max Phase: Preclinical

Molecular Formula: C25H34N2O9

Molecular Weight: 506.55

Molecule Type: Small molecule

Representations

Canonical SMILES:  CC(C)[C@@]1(O)[C@@H](OC(=O)c2ccc[nH]2)/C(=N/O)[C@@]2(C)C[C@]3(O)O[C@]4(C(=O)[C@]13C)[C@H](O)[C@@H](C)CC[C@@]42O

Standard InChI:  InChI=1S/C25H34N2O9/c1-12(2)24(33)17(35-18(29)14-7-6-10-26-14)15(27-34)20(4)11-23(32)21(24,5)19(30)25(36-23)16(28)13(3)8-9-22(20,25)31/h6-7,10,12-13,16-17,26,28,31-34H,8-9,11H2,1-5H3/b27-15-/t13-,16+,17-,20+,21-,22-,23-,24+,25-/m0/s1

Standard InChI Key:  YBPJBZDRLKDVGB-JWCJVRTKSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 506.55

Molecular Weight (Monoisotopic): 506.2264

AlogP: 0.74

#Rotatable Bonds: 3

Polar Surface Area: 181.90

Molecular Species: NEUTRAL

HBA: 10

HBD: 6

#RO5 Violations: 2

HBA (Lipinski): 11

HBD (Lipinski): 6

#RO5 Violations (Lipinski): 3

CX Acidic pKa: 8.90

CX Basic pKa:

CX LogP: 2.12

CX LogD: 2.11

Aromatic Rings: 1

Heavy Atoms: 36

QED Weighted: 0.20

Np Likeness Score: 1.52

References

1. Jefferies PR, Lehmberg E, Lam WW, Casida JE..  (1993)  Bioactive ryanoids from nucleophilic additions to 4,12-seco-4,12-dioxoryanodine.,  36  (9): [PMID:8387597] [10.1021/jm00061a003]

Source

Source(1):

• Scientific Literature